ERO1A and lung adenocarcinoma: Because ERO1L has the potential to affect the secretion of multiple tumor markers, and at the same time is a strong prognostic factor related to lung adenocarcinoma, combining traditional blood markers and the expression of ERO1L in tissues to establish a diagnostic and prognostic model may have a good effect.